Oral Lichenoid lesions induced by programmed cell death protein 1 and cytotoxic T-lymphocyte-associated protein 4 bispecific antibody: a case report

• Hlavní autoři: Qiaozhi Jiang (Autor), Xinyu Chen (Autor), Jiaxuan Wu (Autor), Shanni Wei (Autor), Renchuan Tao (Autor)
• Médium: Kniha
• Vydáno: BMC, 2024-10-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Background Cadonilimab is the first approved dual immune checkpoint inhibitor targeting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), currently utilized for the treatment of various solid tumors. Oral mucosal adverse reactions, such as oral...